Biliary Tract Tumor
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors (NCT05291052) | The First Affiliated Hospital with Nanjing Medical University | 2022-02-14 |
| Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort (NCT04707365) | Assistance Publique - Hôpitaux de Paris | 2021-03-01 |
Track Biliary Tract Tumor automatically
Every clearance here is in the API, with alerts when new ones post.